Clinical Trials Browser

Not yet recruiting × ivosidenib × Tumor-Agnostic × Clear all

NCT06593548 2024-09-19

Lvosidenib (AK112) Combined With CapeOX and Radiotherapy in Patients With Unresectable Metastatic MSS-type Colorectal Cancer

Phase 2 Not yet recruiting

Neoplasm Metastasis